Literature DB >> 27704655

Lower doses of recombinant porcine factor VIII maintain excellent haemostatic efficacy.

K Martin1, R Kasthuri1, M J Mooberry1, S-L Chen2, N S Key1, A D Ma1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27704655      PMCID： PMC5119759          DOI： 10.1111/hae.13038

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  9 in total

1.  High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism.

Authors:  R A Kraaijenhagen; P S in't Anker; M M Koopman; P H Reitsma; M H Prins; A van den Ende; H R Büller
Journal:  Thromb Haemost       Date:  2000-01       Impact factor: 5.249

2.  Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.

Authors:  N S Key; L M Aledort; D Beardsley; H A Cooper; G Davignon; B M Ewenstein; G S Gilchrist; J C Gill; B Glader; W K Hoots; C T Kisker; J M Lusher; C G Rosenfield; A D Shapiro; H Smith; E Taft
Journal:  Thromb Haemost       Date:  1998-12       Impact factor: 5.249

Review 3.  The Leiden Thrombophilia Study (LETS).

Authors:  F J van der Meer; T Koster; J P Vandenbroucke; E Briët; F R Rosendaal
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

Review 4.  Clinical issues in inhibitors.

Authors:  J Astermark; E Santagostino; W Keith Hoots
Journal:  Haemophilia       Date:  2010-07       Impact factor: 4.287

5.  Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

Authors:  Peter W Collins; Sybil Hirsch; Trevor P Baglin; Gerard Dolan; John Hanley; Michael Makris; David M Keeling; Ri Liesner; Simon A Brown; Charles R M Hay
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

6.  A retrospective postlicensure survey of FEIBA efficacy and safety.

Authors:  D Dimichele; C Négrier
Journal:  Haemophilia       Date:  2006-07       Impact factor: 4.287

7.  A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study.

Authors:  Jan Astermark; Sharyne M Donfield; Donna M DiMichele; Alessandro Gringeri; Steven A Gilbert; Jennifer Waters; Erik Berntorp
Journal:  Blood       Date:  2006-09-21       Impact factor: 22.113

8.  Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry.

Authors:  Francesco Baudo; Peter Collins; Angela Huth-Kühne; Hervé Lévesque; Pascual Marco; László Nemes; Fabio Pellegrini; Lilian Tengborn; Paul Knoebl
Journal:  Blood       Date:  2012-05-22       Impact factor: 22.113

9.  Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A.

Authors:  R Kruse-Jarres; J St-Louis; A Greist; A Shapiro; H Smith; P Chowdary; A Drebes; E Gomperts; C Bourgeois; M Mo; A Novack; H Farin; B Ewenstein
Journal:  Haemophilia       Date:  2015-01-27       Impact factor: 4.287
  9 in total
  4 in total

1.  Recombinant porcine FVIII for bleed treatment in acquired hemophilia A: findings from a single-center, 18-patient cohort.

Authors:  Patrick Ellsworth; Sheh-Li Chen; Raj S Kasthuri; Nigel S Key; Micah J Mooberry; Alice D Ma
Journal:  Blood Adv       Date:  2020-12-22

Review 2.  Acquired Hemophilia A: Current Guidance and Experience from Clinical Practice.

Authors:  Allyson M Pishko; Bhavya S Doshi
Journal:  J Blood Med       Date:  2022-05-11

3.  Susoctocog-alfa (Obizur®) in the treatment of nine elderly patients with acquired haemophilia A: an Italian multicentre real world experience.

Authors:  Ezio Zanon; Samantha Pasca; Alessandra Borchiellini; Corrado Lodigiani; Angelo C Molinari; Chiara Ambaglio; Federica Valeri; Paola S Preti; Paolo Moscatelli; Paolo Simioni
Journal:  Blood Transfus       Date:  2020-06-04       Impact factor: 3.443

Review 4.  Review of recombinant anti-haemophilic porcine sequence factor VIII in adults with acquired haemophilia A.

Authors:  Emma Fosbury; Anja Drebes; Anne Riddell; Pratima Chowdary
Journal:  Ther Adv Hematol       Date:  2017-08-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.